electroCore, Inc. (NASDAQ:ECOR) Receives Consensus Rating of “Hold” from Analysts

Shares of electroCore, Inc. (NASDAQ:ECOR) have received an average recommendation of “Hold” from the five brokerages that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, two have assigned a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among analysts that have covered the stock in the last year is $22.00.

ECOR has been the topic of several recent research reports. Zacks Research downgraded shares of electroCore from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 28th. HC Wainwright lowered their target price on shares of electroCore from $25.00 to $18.00 and set a “buy” rating on the stock in a report on Monday, January 26th. Wall Street Zen upgraded electroCore from a “sell” rating to a “hold” rating in a research report on Saturday, November 8th. Brookline Capital Management upgraded electroCore to a “strong-buy” rating in a research note on Tuesday. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of electroCore in a report on Monday, December 29th.

electroCore Trading Down 1.4%

Shares of NASDAQ ECOR opened at $5.47 on Thursday. The stock has a fifty day simple moving average of $5.58 and a two-hundred day simple moving average of $5.45. electroCore has a 1-year low of $4.16 and a 1-year high of $19.49. The firm has a market cap of $43.76 million, a price-to-earnings ratio of -3.20 and a beta of 0.48.

electroCore (NASDAQ:ECOR) last issued its quarterly earnings results on Wednesday, November 5th. The company reported ($0.40) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.07). electroCore had a negative net margin of 47.46% and a negative return on equity of 447.87%. The firm had revenue of $8.69 million for the quarter, compared to analysts’ expectations of $7.84 million. Analysts forecast that electroCore will post -1.49 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. International Assets Investment Management LLC boosted its stake in electroCore by 15.2% during the fourth quarter. International Assets Investment Management LLC now owns 88,720 shares of the company’s stock valued at $398,000 after buying an additional 11,700 shares during the period. FNY Investment Advisers LLC bought a new position in electroCore in the 4th quarter worth about $82,000. Jaffetilchin Investment Partners LLC raised its holdings in shares of electroCore by 7.4% in the 4th quarter. Jaffetilchin Investment Partners LLC now owns 52,363 shares of the company’s stock valued at $235,000 after acquiring an additional 3,600 shares in the last quarter. Two Sigma Investments LP boosted its position in shares of electroCore by 20.8% during the 3rd quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock valued at $122,000 after acquiring an additional 4,231 shares during the last quarter. Finally, Jane Street Group LLC boosted its position in shares of electroCore by 114.4% during the 1st quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock valued at $246,000 after acquiring an additional 19,599 shares during the last quarter. 26.74% of the stock is currently owned by hedge funds and other institutional investors.

electroCore Company Profile

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.